World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
132
Citations
56218
World Ranking
220
National Ranking
144

Medicine

D-Index
132
Citations
56220
World Ranking
2333
National Ranking
1318

Jay A. Berzofsky publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Jay A. Berzofsky sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 646 publications — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Jay A. Berzofsky D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Jay A. Berzofsky sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 132 D-Index — 96th percentile

96% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 1995 - Fellow of the American Association for the Advancement of Science (AAAS)
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Jay A. Berzofsky is affiliated with the National Institutes of Health in the United States. Their research spans several fields, primarily focusing on immunology, microbiology, medicine, and biochemistry, genetics, and molecular biology.

The main subfields where they have contributed include immunology, oncology, molecular biology, infectious diseases, and epidemiology. Their work centers on topics such as immunotherapy and immune responses, immune cell function and interaction, cancer immunotherapy and biomarkers, SARS-CoV-2 and COVID-19 research, vaccines and immunoinformatics approaches, COVID-19 clinical research studies, and CAR-T cell therapy research.

Among the recent publications, the following papers highlight the scope and focus of their research:

  • Platelets control liver tumor growth through P2Y12-dependent CD40L release in NAFLD (2022, Cancer Cell)
  • Unique challenges for glioblastoma immunotherapy-discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think Tank (2020, Neuro-Oncology)
  • Protection against SARS-CoV-2 infection by a mucosal vaccine in rhesus macaques (2021, JCI Insight)
  • Potential SARS-CoV-2 Immune Correlates of Protection in Infection and Vaccine Immunization (2021, Pathogens)
  • SARS-CoV-2 Spike Protein Suppresses ACE2 and Type I Interferon Expression in Primary Cells From Macaque Lung Bronchoalveolar Lavage (2021, Frontiers in Immunology)

The frequent co-authors collaborating with Jay A. Berzofsky include:

  • Purevdorj B. Olkhanud
  • Yongjun Sui
  • Hoyoung Maeng
  • Jianping Li
  • Tanya Hoang

Their work is often published in venues such as The Journal of Immunology, Frontiers in Immunology, Regular and Young Investigator Award Abstracts, Faculty Opinions - Post-Publication Peer Review of the Biomedical Literature, and JCI Insight, reflecting a broad engagement across immunology and related fields.

Jay A. Berzofsky has received recognition through awards such as the Fellow of the American Association for the Advancement of Science (AAAS) in 1995 and membership in the Association of American Physicians.

Best Publications

  • Gut microbiome–mediated bile acid metabolism regulates liver cancer via NKT cells

    Chi Ma;Miaojun Han;Bernd Heinrich;Qiong Fu

  • Human retroviruses and AIDS, 1991. [CONTAINS GLOSSARY]

    G. Myers;B. Korber;J.A. Berzofsky;G.N. Pavlakis

  • THE ANTIGENIC STRUCTURE OF PROTEINS: A REAPPRAISAL

    D C Benjamin;J A Berzofsky;I J East;F R Gurd

  • Human retroviruses and AIDS 1996. A compilation and analysis of nucleic acid and amino acid sequences

    G. Myers;B. Foley;B. Korber

  • NKT cell–mediated repression of tumor immunosurveillance by IL-13 and the IL-4R–STAT6 pathway

    Masaki Terabe;So Matsui;Nancy Noben-Trauth;Hangjiong Chen

  • Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function.

    Rong Zeng;Rosanne Spolski;Steven E. Finkelstein;Sang Kon Oh

  • Hydrophobicity scales and computational techniques for detecting amphipathic structures in proteins

    James L. Cornette;Kemp B. Cease;Hanah Margalit;John L. Spouge

  • Transforming Growth Factor-β Production and Myeloid Cells Are an Effector Mechanism through Which CD1d-restricted T Cells Block Cytotoxic T Lymphocyte–mediated Tumor Immunosurveillance Abrogation Prevents Tumor Recurrence

    Masaki Terabe;So Matsui;Jong-Myun Park;Mizuko Mamura

  • T-cell antigenic sites tend to be amphipathic structures.

    Charles Delisi;Jay A. Berzofsky

  • Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy

    Martha A. Alexander-Miller;Graham R. Leggatt;Jay A. Berzofsky

  • Intrinsic and Extrinsic Factors in Protein Antigenic Structure

    Jay A. Berzofsky

  • Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs.

    H Takahashi;T Takeshita;B Morein;S Putney

  • Role of T-cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection.

    Alan Sher;Ricardo T. Gazzinelli;Isabelle P. Oswald;Mario Clerici

  • Prediction of immunodominant helper T cell antigenic sites from the primary sequence.

    H Margalit;J L Spouge;J L Cornette;K B Cease

  • An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes.

    Hidemi Takahashi;Joseph Cohen;Anne Hosmalin;Kemp B. Cease

  • Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses

    Jason A. Hall;Jason A. Hall;Nicolas Bouladoux;Cheng Ming Sun;Elizabeth A. Wohlfert

  • Phase I Study of GC1008 (Fresolimumab): A Human Anti-Transforming Growth Factor-Beta (TGFβ) Monoclonal Antibody in Patients with Advanced Malignant Melanoma or Renal Cell Carcinoma

    John C. Morris;Antoinette R. Tan;Thomas E. Olencki;Geoffrey I. Shapiro

  • Cell-Mediated Immune Response to Human Immunodeficiency Virus (HIV) Type 1 in Seronegative Homosexual Men with Recent Sexual Exposure to HIV-1

    Mario Clerici;Janis V. Giorgi;Janis V. Giorgi;Janis V. Giorgi;Chen Cheng Chou;Vaheideh K. Gudeman;Vaheideh K. Gudeman;Vaheideh K. Gudeman

  • Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro

    Mario Clerici;Daniel R. Lucey;Jay A. Berzofsky;Ligia A. Pinto

  • Strategies for designing and optimizing new generation vaccines

    Jay A. Berzofsky;Jeffrey D. Ahlers;Igor M. Belyakov

Frequent Co-Authors

Masaki Terabe
Masaki Terabe National Institutes of Health
Igor M. Belyakov
Igor M. Belyakov University of Michigan–Ann Arbor
Gene M. Shearer
Gene M. Shearer National Institutes of Health
Mario Clerici
Mario Clerici University of Milan
Charles DeLisi
Charles DeLisi Boston University
David H. Margulies
David H. Margulies National Institutes of Health
Genoveffa Franchini
Genoveffa Franchini National Institutes of Health
Bernard Moss
Bernard Moss National Institutes of Health
John C. Morris
John C. Morris Washington University in St. Louis
Hanah Margalit
Hanah Margalit Hebrew University of Jerusalem

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various healthcare and research careers. Many students explore related online degrees that complement immunology knowledge and expand their professional opportunities. For those interested in clinical roles, accelerated nursing programs provide a faster track into nursing practice.

For example, nurse practitioner accelerated program options allow students with a bachelor’s degree to quickly transition into advanced nursing roles. Similarly, online RN programs for non nurses in Florida offer accessible pathways for individuals without prior nursing experience to enter the profession through flexible, remote learning.

If you’re seeking programs with lower entry barriers, easiest accelerated nursing programs to get into can be a great starting point. These programs focus on streamlined admissions and practical coursework to help learners achieve their nursing goals efficiently.

Additionally, fastest and easiest LPN programs provide a quick route to become licensed practical nurses, a vital support role in healthcare settings. Combining immunology expertise with nursing qualifications can enhance job prospects in hospitals, laboratories, and community care.

Exploring these related online degrees can maximize your impact in health sciences, blending immunology with hands-on patient care and advanced clinical skills.

Learn more about paths that fit your passion through nurse practitioner accelerated program, online RN programs for non nurses in Florida, easiest accelerated nursing programs to get into, and fastest and easiest LPN programs.

Best Scientists Citing Jay A. Berzofsky

Trending Scientists

Recently Published Articles